Paid articlePaywallJohnson & Johnson: The Dividend King Is Back:
Johnson & Johnson is regaining momentum with strong growth in its innovative segments, making it an attractive ...
seekingalpha.com/article/4716746-johnson-and-johnson-the-dividend-king-is-back
Story Details
| Last Updated | |
| Total Articles | 1 |
Main Topics
U.S multinational medical devices, pharmaceutical and consumer packaged goods manufacturer
Similar to This
Previous
FDA grants J&J accelerated approval for head and neck cancer treatment: The US Food and Drug Administration on Thursday granted accelerated approval to Johnson & ...
reuters.com/legal/litigation/fda-grants-jj-accelerated-approval-head-neck-cancer-treatment-2026-11-05/
Gardiner Harris, investigative journalist: ‘No industry has been as criminal as the pharmaceutical industry’
english.elpais.com/society/2026-11-01/gardiner-harris-investigative-journalist-no-industry-has-been-as-criminal-as-the-pharmaceutical-industry.html
Paid articlePaywall Johnson & Johnson reports 94% success rate in trial of coronary artery device: Johnson & Johnson’s Shockwave Javelin showed strong 30-day trial results in ...
seekingalpha.com/news/4661897-johnson-and-johnson-reports-94-percent-success-rate-in-trial-of-coronary-artery-device
Johnson & Johnson’s prostate cancer drug shrinks tumours in early-stage trial: JNJ-6143 demonstrates strong PSA reduction in advanced cases
ebx.sh/IxIUB5
Paid articlePaywall How To Build A $25,000 Dividend Portfolio, Johnson & Johnson As Your Core Holding
seekingalpha.com/article/4740818-how-to-build-25000-dividend-portfolio-johnson-and-johnson-as-core-holding
Paid articlePaywall 3 Dividend Kings So You Can Sleep Well At Night: Discover why Dividend Kings like Coca-Cola, Johnson & Johnson, and Walmart are top long-term investments for ...
seekingalpha.com/article/4739580-3-dividend-kings-so-you-can-sleep-well-at-night
Johnson & Johnson must pay $15 million to Connecticut man who says its talc gave him cancer, jury finds
deccanherald.com/business/companies/johnson-johnson-must-pay-15-million-to-connecticut-man-who-says-its-talc-gave-him-cancer-jury-finds-3233913
Paid articlePaywall Banner Corporation 2024 Q2 - Results - Earnings Call Presentation: The following slide deck was published by Banner Corporation in conjunction with their 2024 Q2 ...
seekingalpha.com/article/4704828-banner-corporation-2024-q2-results-earnings-call-presentation
Paid articlePaywall Johnson & Johnson Q2 Earnings Preview: Scrutinizing Its Earnings Quality: Johnson & Johnson will announce its Q2 2024 results on Wednesday, July 17 ...
seekingalpha.com/article/4703489-johnson-and-johnson-q2-earnings-preview-scrutinizing-its-earnings-quality
Paid articlePaywall Johnson & Johnson: A Lot Of Moving Parts, But Perhaps Finally Lurching In The Right Direction
seekingalpha.com/article/4702267-johnson-and-johnson-a-lot-of-moving-parts-but-perhaps-finally-lurching-in-the-right-direction
Paid articlePaywall Two High Conviction Dividend Buys For This Upside-Down Market: FOMO is driving stock market decisions, and investing in discounted dividend stocks may be a ...
seekingalpha.com/article/4700420-two-high-conviction-dividend-buys-for-this-upside-down-market
Paid articlePaywall Johnson & Johnson: Market Will Regret The Overreaction: Johnson & Johnson stock prices have been consistently declining in the recent 1~2 years ...
seekingalpha.com/article/4696746-johnson-and-johnson-market-will-regret-the-overreaction
Paid articlePaywall Johnson & Johnson: Vital Signs Decent, A Compelling Value Case: Johnson & Johnson's diversified portfolio and pipeline provide stability, despite weaknesses in ...
seekingalpha.com/article/4695289-johnson-and-johnson-vital-signs-decent-a-compelling-value-case
Paid articlePaywall Johnson & Johnson: Buy This Bargain Before It's Gone: Johnson & Johnson exceeds expectations with strong financial results and impressive sales growth ...
seekingalpha.com/article/4684406-johnson-johnson-earnings-buy-this-bargain-before-it-is-gone
Paid articlePaywall Johnson & Johnson: Doubling Down On This 2024 Dog Of The Dow: Johnson & Johnson (JNJ) is poised for growth with solid financials, a consistent dividend streak ...
seekingalpha.com/article/4683388-johnson-and-johnson-doubling-down-on-this-2024-dog-of-the-dow-jnj-stock
Paid articlePaywall Johnson & Johnson: One Penny, Per Hour, Forever: Johnson & Johnson is a powerhouse with an amazing quality rating and very long, and successful track record ...
seekingalpha.com/article/4662918-johnson-and-johnson-one-penny-per-hour-forever
Paid articlePaywall Johnson & Johnson: A Defensive Dividend King Set To Outperform The S&P 500: Johnson & Johnson trades at an attractive valuation with potential for dividend ...
seekingalpha.com/article/4661269-johnson-and-johnson-stock-defensive-dividend-king-set-outperform-sp-500
Next